STAT Plus: Mystery solved: the pharma-backed group with a lot to say on Trump’s pitch to end drug rebates
APSTOCK
Many of the thousands of publicly available comments reflect the same wording from a Washington-based advocacy group with pharma ties.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario